Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure Reply

被引：0
|
作者：
van der Meer, P. [1 ]
van Veldhuisen, D. J. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands
来源：
HEART | 2009年 / 95卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1279 / 1279
页数：1
相关论文
共 50 条
  • [41] A Meta-Analysis of Remote Monitoring of Heart Failure Patients Reply
    Auricchio, Angelo
    Klersy, Catherine
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (14) : 1506 - 1507
  • [42] Network Meta-analysis of Heart Failure Prevention by Antihypertensive Drugs Reply
    Sciarretta, Sebastiano
    Tocci, Giuliano
    Palano, Francesca
    Volpe, Massimo
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 472 - 473
  • [43] Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective
    Cheng, Hon Wai Benjamin
    Chan, Kwok Ying
    Lau, Hoi To
    Man, Ching Wah
    Cheng, Suk Ching
    Lam, Carman
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2017, 34 (04) : 380 - 384
  • [44] The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions
    Palazzuoli, Alberto
    Ruocco, Gaetano
    Pellegrini, Marco
    De Gori, Carmelo
    Del Castillo, Gabriele
    Giordano, Nicola
    Nuti, Ranuccio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 641 - 650
  • [45] META-ANALYSIS AND SELECTIVE PUBLICATION BIAS - REPLY
    DAWES, RM
    LANDMAN, J
    WILLIAMS, M
    AMERICAN PSYCHOLOGIST, 1984, 39 (01) : 74 - 75
  • [46] Development of Artificial Intelligence for Clinical Decision Support to Optimizes Erythropoietin-Stimulating Agents in Patients with CKD
    Kurathong, Sathit
    Buranasaksathien, Pattanan
    Pongsitisak, Wanjak
    Trakarnvanich, Thananda
    Ngamvichchukorn, Tanun
    Jaturapisanukul, Solos
    Laungchuaychok, Punnawit
    Suphatheerawatr, Nitcha
    Limbutara, Kavee
    Teerawongsakul, Padoemwut
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [47] Important bias in the Astragalus meta-analysis -: Reply
    McCulloch, Michael F.
    See, Caylie
    Shu, Xiao-juan
    Broffman, Michael D.
    Kramer, Alan
    Fan, Wei-yu
    Gao, Jin
    Lieb, Whitney
    Shieh, Kane
    Colford, John M., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3216 - 3217
  • [48] Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis
    Desai, Akshay
    Lewis, Eldrin
    Solomon, Scott
    McMurray, John J. V.
    Pfeffer, Marc
    EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (09) : 936 - 942
  • [49] Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
    Ohki, Kohji
    Wakui, Hiromichi
    Uneda, Kazushi
    Azushima, Kengo
    Haruhara, Kotaro
    Kinguchi, Sho
    Urate, Shingo
    Yamada, Takayuki
    Yamaji, Takahiro
    Kobayashi, Ryu
    Kanaoka, Tomohiko
    Minegishi, Shintaro
    Ishigami, Tomoaki
    Fujikawa, Tetsuya
    Toya, Yoshiyuki
    Tamura, Kouichi
    KIDNEY DISEASES, 2020, 6 (04) : 299 - 307
  • [50] Amgen has issued a 'Dear Healthcare Professional' letter advising labelling changes for the erythropoietin-stimulating agents
    Reactions Weekly, 2008, 1215 (1) : 3 - 3
12345